CAS 13057-17-5
:Etere bromometil metilico
- 1-Bromomethyl methyl ether
- Bmme
- Bromo(Methoxy)Methane
- Bromomethoxymethane
- Bromomethylil Methul Ether
- Ether, bromomethyl methyl
- Methane, bromomethoxy-
- Methoxymethyl bromide
- NSC 155338
- Bromomethyl methyl ether
Bromomethyl Methyl Ether
CAS:Formula:C2H5BrOPurezza:>95.0%(GC)Colore e forma:Colorless to Light yellow to Light orange clear liquidPeso molecolare:124.97Bromomethyl methyl ether, tech. 90%
CAS:Bromomethyl methyl ether is used as reagent for protection of OH groups as their methoxymethyl (MOM) ethers. It is used in enantiocontrolled synthesis of intermediate containing carbons 18 to 35 of the macrocyclic immunosuppressant FK-506. It was used in the synthesis of 1-methoxymethyl-4-tritylthio
Formula:C2H5BrOPurezza:90%Colore e forma:Liquid, Clear colorless to yellowPeso molecolare:124.97Bromomethyl methyl ether
CAS:Bromomethyl methyl ether
Formula:C2H5BrOPurezza:95%Colore e forma: clear. colourless liquidPeso molecolare:124.9645g/molBromomethyl methyl ether
CAS:Formula:C2H5BrOPurezza:90.0%Colore e forma:Liquid, ClearPeso molecolare:124.965Bromomethyl methyl ether
CAS:Bromomethyl methyl ether (BME) is a synthetic compound that can be used in pharmaceutical preparations. BME has been shown to have positive effects on blood disorders, such as the treatment of hematopoietic cells and c-c chemokine receptor. It also has anti-metastatic properties in vivo, which may be due to its ability to inhibit tumor growth and induce apoptosis in colorectal cancer cells. BME also has biological properties that are similar to those of fatty acids, which include the ability to activate protein kinase C and the inhibition of phospholipase A2. These biological properties make BME an ideal candidate for use in biodiesel production.Formula:C2H5BrOPurezza:Min. 95%Colore e forma:Clear LiquidPeso molecolare:124.96 g/molBromomethyl Methyl Ether
CAS:Prodotto controllatoApplications Bromomethyl Methyl Ether acts as a reagent in the synthesis and evaluation of hydroxymethyl-aminocyclitols as glycosidase inhibitors, preparation of pyridine derivatives for minimizing CYP2C9 inhibition for cancer therapy. Also a reagent in the discovery of GBT 440, an orally bioavailable R state stabilizer of sickle cell Hb.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Trapero, A., et al.: J. Org. Chem., 80, 3512 (2015); Zak, M., et al.: J. Med. Chem., 59, 8345 (2016); Metcalf, B.; et al.: ACS Med. Chem. Lett., 8, 321 (2017)Formula:C2H5BrOColore e forma:NeatPeso molecolare:124.96







